Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
No ratio data was found for MMTX.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
No quarterly
income statement data was found for MMTX.
Recent news
Company coverage with links to the original publishers.
Monteverde & Associates PC announced investigations into multiple companies involved in M&A transactions, including XOMA Royalty Corporation's proposed sale to Ligand Pharmaceuticals at $39.00 per share in cash. The firm is examining whether the deal terms are fair to shareholders.
Monteverde & Associates PC, a class action securities firm, has announced investigations into Miluna Acquisition Corp. (MMTX) regarding its merger with CADV Ventures S.A., as well as investigations into XOMA Royalty Corporation (XOMA) and Helix Energy Solutions Group, Inc. (HLX). The firm is seeking shareholders with concerns about potential fairness issues in these transactions.
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
No declared upcoming dividend found.
No prior dividend records found.
Stock splits
Historical share-structure events and their execution dates.